Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Alexandria – page 12

142 clinical trials in Alexandria, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Alexandria at a glance
142
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

142 trials in Alexandria

Open in trial search

Pleural mesothelioma

Not recruiting

Study of Volrustomig with Carboplatin and Pemetrexed for Patients with Unresectable Pleural Mesothelioma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Aminocaproic Acid
  • Sponsor:AstraZeneca AB

Follicular lymphoma+1

Not recruiting

Study of Tafasitamab, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Follicular or Marginal Zone Lymphoma

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Incyte Corp.

Study of Loncastuximab Tesirine and Rituximab for Untreated Unfit or Frail Patients with Diffuse Large B-cell Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:ADCT-402
  • Sponsor:ADC Therapeutics SA

Study of Zilovertamab Vedotin with Drug Combination for Patients with Diffuse Large B-Cell Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Merck Sharp & Dohme LLC

Polycythaemia vera

Not recruiting

Study of SLN124 for Patients with Polycythemia Vera

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Tmprss6 Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
  • Sponsor:Silence Therapeutics PLC

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

B-cell lymphoma

Not recruiting

Study of Loncastuximab Tesirine for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma or High-Grade B-Cell Lymphoma After CAR T-Cell Therapy

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Loncastuximab Tesirine
  • Sponsor:Humanitas Mirasole S.p.A.

Study of Romidepsin and Drug Combination for Young Patients with Peripheral T-Cell Lymphomas Before Stem Cell Transplantation

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Romidepsin
  • Sponsor:Fondazione Italiana Linfomi Ets

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum der Universitaet Muenchen AöR

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Alexandria

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking research focusing on blood cancers and related disorders, including studies on innovative treatments for lymphoma, leukemia, and multiple myeloma. Clinical trials are evaluating novel therapeutic combinations and targeted approaches.

  • Diffuse Large B-Cell Lymphoma
  • Acute Myeloid Leukemia
  • Follicular Lymphoma

Investigations include immunotherapy combinations and maintenance strategies for improved patient outcomes.

02 Respiratory Medicine

Studies focusing on preventing and treating respiratory infections and conditions, with particular emphasis on vulnerable populations. Research includes vaccine development and therapeutic interventions.

  • Respiratory Syncytial Virus
  • Upper Respiratory Tract Infections
  • Lung Cancer

Trials are exploring novel treatments and preventive strategies for respiratory conditions.

03 Cardiovascular Research

Important studies in heart failure prevention and treatment, investigating new therapeutic combinations and strategies to reduce cardiovascular risks in high-risk populations.

  • Heart Failure Prevention
  • Cardiovascular Risk Management

Research focuses on innovative drug combinations to prevent heart failure events and improve outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.